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In a Swedish population-based case–control study, smoking showed no convincing association with risk of postmenopausal breast
cancer – regardless of timing or level of smoking exposure – either overall or among subgroups.
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The role of smoking in breast cancer aetiology has been extensively
studied (Band et al, 2002; Collaborative Group on Hormonal
Factors in Breast Cancer, 2002; Terry and Rohan, 2002; Lawlor
et al, 2004). Yet, the association remains equivocal and much
debated (Terry and Rohan, 2002; Johnson, 2005). Smoking has
been proposed to increase breast cancer risk, based on studies
showing breast epithelial genotoxicity of tobacco-related com-
pounds (Morabia, 2002), but also to exert an ‘anti-oestrogenic
effect’ and thence to reduce risk (Terry and Rohan, 2002).
We present results from a large population-based study, on the
associations between the hypothesised ‘carcinogenetic mode’ of
smoking, that is smoking prior to first birth or among nulliparous
women, vs the ‘anti-oestrogenic mode’, that is recent smoking and
risk of breast cancer.
MATERIALS AND METHODS
Study population
We conducted a case–control study of breast cancer among all
Swedish-born women aged 50–74 years, in Sweden between
October 1993 and March 1995.
Cases were women with an incident invasive breast cancer,
identified through the six Regional Cancer Registries. Out of 3979
eligible cases, 3345 (84%) participated. Controls were age-
frequency matched according to the age distribution of cases,
and randomly selected from the study population, using the
Registry of the Total Population. Of the 4188 eligible controls, 3454
(82%) participated in the study.
Data collection
Study participants completed a postal questionnaire on average 4
months after diagnosis. Participants were asked in detail about
their life-course smoking history and about other established
breast cancer risk factors. Telephone interviews were conducted
among controls who declined completion of the postal ques-
tionnaires. Out of all participating controls, 14% contributed
information in this manner.
Classification of smoking history
Women were defined as ever smokers if they had smoked a total of
at least 100 cigarettes, or if they had smoked regularly for at least 1
year. Women were attributed a 10-year duration of smoking for
each 10-year age period they reported to be smokers, if they
smoked during age-periods before and after. If not, they were
attributed a duration of 5 years for each 10-year age period they
reported to be smokers. Lifetime pack-years was calculated as the
average smoking intensity multiplied by the estimated smoking
duration.
Statistical analyses
Relative risks were estimated using unconditional logistic regres-
sion, adjusted for age in 5-year categories, yielding odds ratios
(ORs) and 95% confidence intervals (CIs). Possible confounders
were included as covariates in age-adjusted models one at a time
and included in the final models if they affected parameter
estimates more than 10%. The tested covariates were age at first
birth, body mass index, socioeconomic position, alcohol intake 1
year before data collection, age at menarche and menopause,
parity, use of menopausal hormone therapy, age at menopause,
family history of breast cancer and benign breast disease. The final
models were adjusted for age, age at first birth, body mass index
and alcohol intake.
Linear trends and effect modification were assessed using Wald
tests.
Analyses were performed using SAS system, version 9.1 (SAS
Institute, Carey, NC, USA). All statistical significance levels
(P-values) quoted are two-sided.
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The prevalence of smoking was similar among cases and
controls, with 24 and 23% being current smokers, and 22 and
20% being past smokers, respectively. The distribution of
established breast cancer risk factors varied significantly with
smoking status, such that ever smokers were younger, taller,
thinner, consumed more alcohol, had on average an earlier age at
menarche, first birth, and menopause, and had used menopausal
hormone therapy to a higher extent than never smokers (data not
shown).
Neither current nor past smokers were at an altered risk
of breast cancer as compared to never smokers, regardless of
smoking intensity, total smoking duration or total number of
pack-years (Table 1). Neither smoking initiation in adolescence
nor prior to first birth was significantly related to breast cancer
risk, again regardless of whether the woman reported to be a
current or past smoker (Table 1).
The relationships between breast cancer and current smoking
did not vary significantly with levels of other characteristics,
except for alcohol consumption (Figure 1). A similar pattern was
seen with smoking initiated before first birth (data not shown).
Lastly, current smoking as compared to never smoking among
overweight postmenopausal women was not associated with any
alteration in risk, even when smoking was commenced after the
first birth (OR 1.0 (95% CI 0.6–1.7), based on 35 and 36 exposed
cases and controls, respectively).
DISCUSSION
We did not observe any association between smoking at any time
period, duration or intensity, and the risk of breast cancer – either
overall or among most subgroups. Yet, we found some evidence of
an interaction between alcohol consumption and smoking.
Our null finding is consistent with results from a collaborative
reanalysis including 53 studies (Collaborative Group on Hormonal
Factors in Breast Cancer, 2002). This analysis was restricted to
teetotallers, since the relationship between smoking and breast
cancer was observed to be substantially confounded by alcohol
consumption. We believe that residual confounding may explain
our finding of a positive association between smoking and breast
cancer among women who reported a high consumption.
Smoking has been proposed to evoke a dual effect on breast
cancer risk (Terry and Rohan, 2002). Firstly, smoking is
hypothesised to reduce breast cancer risk via an ‘anti-oestrogenic
effect’ since smokers experience effects mimicking low endogenous
oestrogen levels, like earlier menopause, lower relative weight,
increased risk for oestoporos, decreased risk for endometrial
cancer, as well as reduced levels of oestrone and oestradiol after
menopausal hormone therapy. Yet, smoking does not seem to
affect serum oestrogen levels in premenopausal or postmenopausal
women (Key et al, 1991). Nevertheless, any ‘antioestrogen-
mediated’ inverse association between smoking and breast cancer
may be more pronounced among women with high endogenous or
exogenous sex steroid exposure, including premenopausal women,
Table 1 Relative risk of breast cancer in relation to current and past smoking duration, intensity and initiation
Smoking measure Cases/controls OR
a (95% CI) Cases/controls OR
a (95% CI)
Never smoker 1526/1453 1.0 (ref) 1526/1453 1.0 (ref)
Current smokers Past smokers
Ever smoker 657/589 1.0 (0.9–1.2) 601/541 1.0 (0.9–1.1)
Duration of smoking, years
1–10 22/28 0.7 (0.4–1.3) 255/216 1.0 (0.8–1.3)
11–30 173/147 1.0 (0.8–1.3) 282/257 1.0 (0.8–1.2)
430 457/406 1.1 (0.9–1.2) 61/65 0.9 (0.7–1.4)
P for linear trend
b 0.58 0.95
Cigarettes per day
1–10 282/259 1.0 (0.9–1.3) 373/349 1.0 (0.8–1.2)
11–20 347/297 1.1 (0.9–1.3) 196/170 1.0 (0.8–1.3)
420 23/25 0.8 (0.4–1.4) 29/19 1.2 (0.7–2.2)
P for linear trend
b 0.71 0.73
Pack-years
1–10 114/114 0.9 (0.7–1.2) 391/359 1.0 (0.8–1.1)
11–20 193/187 1.0 (0.8–1.2) 118/103 1.0 (0.8–1.3)
21–30 229/153 1.4 (1.1–1.7) 61/59 0.9 (0.6–1.3)
430 116/127 0.9 (0.7–1.2) 28/17 1.5 (0.8–2.8)
P for linear trend
b 0.77 0.69
Age at initiation, years
o20 359/281 1.2 (1.0–1.4) 300/265 1.0 (0.8–1.2)
20–29 196/204 0.9 (0.7–1.1) 221/202 1.0 (0.8–1.2)
X30 99/99 1.0 (0.7–1.3) 77/71 1.1 (0.8–1.5)
P for linear trend
b 0.73 0.99
Initiation in relation to birth
Prior 284/223 1.2 (0.9–1.4) 289/260 1.0 (0.8–1.2)
At around the same time 196/204 1.0 (0.8–1.2) 157/159 1.0 (0.8–1.3)
Following 89/99 1.0 (0.7–1.4) 72/63 1.3 (0.9–1.9)
aAdjusted for age (5-year categories), age at first birth (nulliparous, 20–24, 25–29, X30 years), recent body mass index (in quintiles) and recent alcohol consumption (no intake,
o5, 5o10, 410gday
1).
bP for Wald w
2, test of linear effect using the original continuous variable.
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and users of menopausal hormone therapy. Yet, neither our data
nor those from the pooled reanalysis support any protective effect
of smoking among women with such characteristics (Collaborative
Group on Hormonal Factors in Breast Cancer, 2002).
Smoking has further been proposed to initiate breast carcino-
genesis through a genotoxic impact of tobacco-related compounds
(Morabia, 2002). The breast epithelium is thought to proliferate
rapidly during the period between menarche and first pregnancy
and therefore to be especially vulnerable to malignant transforma-
tion (Russo and Russo, 1980). Corroborating these lines of
reasoning, Band et al (2002) reported an increased risk with
smoking initiated prior to first birth and among nulliparous
women. However, a recent meta-analysis showed a null association
between smoking prior to the birth of a first child and risk of
breast cancer (Lawlor et al, 2004).
We tested the suggested hypothesis (Band et al, 2002) that smoking
may reduce breast cancer risk among women through an ‘anti-
oestrogenic effect’ – if not offset by a purported carcinogenic effect of
smoking before first pregnancy. We could, however, not discern any
impact of recent smoking among overweight/obese postmenopausal
women who commenced smoking after their first birth.
A larger proportion of controls than cases were excluded from
the analyses since 14% of all eligible controls participated via a
telephone interview that did not elicit information on alcohol
consumption. Sensitivity analyses evaluating the exclusion of such
controls were, however, not indicative of any introduction of
selection bias. Subject to debate, passive smoking has been
proposed to increase breast cancer risk per se and to confound
estimates of the relative risks for breast cancer associated with
active smoking (Johnson, 2005). We did not collect information
about passive smoking. Yet, the available evidence suggests
that the effect (if any) of passive smoking may be confined to
premenopausal women (Johnson, 2005; Miller et al, 2007). Since
our study population is postmenopausal, we believe that
confounding by passive smoking is an improbable explanation of
our null findings. Lastly, such confounding appears unlikely since
active smokers are indeed heavily exposed passive smokers.
In summary, results from this study do not support any
association between active smoking and the risk of breast cancer.
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Figure 1 Relative risk of breast cancer for current smokers as compared to never smokers, by different characteristics. Black squares indicate odds ratios
(ORs) area, which is proportional to the amount of information contributed (ie, to the inverse of the variance of the logarithm of the OR). Lines indicate 95%
confidence intervals. All estimates were adjusted for age, age at first birth, recent body mass index and recent alcohol consumption when applicable. Recent
denotes 1 year before data collection. (A) Women ever using menopausal hormone therapy excluded. (B) Current and past use defined as last use p6
months and 46 months before diagnosis/pseudodiagnosis, respectively.
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